These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8341696)

  • 1. Dimerization and DNA binding alter phosphorylation of Fos and Jun.
    Abate C; Baker SJ; Lees-Miller SP; Anderson CW; Marshak DR; Curran T
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6766-70. PubMed ID: 8341696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts.
    Baker SJ; Kerppola TK; Luk D; Vandenberg MT; Marshak DR; Curran T; Abate C
    Mol Cell Biol; 1992 Oct; 12(10):4694-705. PubMed ID: 1328860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1.
    Ramirez-Carrozzi V; Kerppola T
    Mol Cell Biol; 2003 Mar; 23(5):1737-49. PubMed ID: 12588992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
    Leonard DA; Rajaram N; Kerppola TK
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4913-8. PubMed ID: 9144164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
    Deng T; Karin M
    Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of a dominant-negative mutant of c-Jun.
    Brown PH; Chen TK; Birrer MJ
    Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy transfer analysis of Fos-Jun dimerization and DNA binding.
    Patel LR; Curran T; Kerppola TK
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7360-4. PubMed ID: 8041795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos.
    Nikitovic D; Holmgren A; Spyrou G
    Biochem Biophys Res Commun; 1998 Jan; 242(1):109-12. PubMed ID: 9439619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA bending by Fos-Jun and the orientation of heterodimer binding depend on the sequence of the AP-1 site.
    Rajaram N; Kerppola TK
    EMBO J; 1997 May; 16(10):2917-25. PubMed ID: 9184235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
    J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA binding and transactivation properties of Fos variants with homodimerization capacity.
    Porte D; Oertel-Buchheit P; John M; Granger-Schnarr M; Schnarr M
    Nucleic Acids Res; 1997 Aug; 25(15):3026-33. PubMed ID: 9304112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun.
    Humar M; Loop T; Schmidt R; Hoetzel A; Roesslein M; Andriopoulos N; Pahl HL; Geiger KK; Pannen BH
    Int J Biochem Cell Biol; 2007; 39(12):2278-88. PubMed ID: 17689131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escape from redox regulation enhances the transforming activity of Fos.
    Okuno H; Akahori A; Sato H; Xanthoudakis S; Curran T; Iba H
    Oncogene; 1993 Mar; 8(3):695-701. PubMed ID: 8437852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fos is phosphorylated by p34cdc2, cAMP-dependent protein kinase and protein kinase C at multiple sites clustered within regulatory regions.
    Abate C; Marshak DR; Curran T
    Oncogene; 1991 Dec; 6(12):2179-85. PubMed ID: 1766667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution.
    Malnou CE; Brockly F; Favard C; Moquet-Torcy G; Piechaczyk M; Jariel-Encontre I
    J Biol Chem; 2010 Feb; 285(9):6552-62. PubMed ID: 20053986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the transduction pathway involved in c-fos and c-jun expression induced by Aggregatibacter actinomycetemcomitans lipopolysaccharides in human gingival fibroblasts.
    Gutiérrez-Venegas G; Castillo-Alemán R
    Int Immunopharmacol; 2008 Nov; 8(11):1513-23. PubMed ID: 18621151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.